CANOPY GROWTH CORPORATION Investor Presentation March 2020 - - PowerPoint PPT Presentation

CANOPY GROWTH CORPORATION Investor Presentation March 2020

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

• ,)$(N:()-($%*,G%,'%(//(-*$%,)G%*"(%9,6&+)FJ%

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

FORWARD-LOOKING STATEMENT

T

!"#"$%&'&$(($)*+%"*,

• )$.&"%!/#*./%*&(01#/&*$&1&-$2+#/3&/4/2+*"$%&(01#/&

5+"63"%7&5)1%3#&1%3&()$3+2*#&$-&*$31,&1%3&*$.$))$8 2$.."**/3&*$&3/6"!/)"%7&#01)/0$63/)&!16+/

KEY THEMES

U

VISION & OPPORTUNITY

BUILDING A PROFITABLE WORLD-CLASS CANNABIS COMPANY

V

7)$##&)/!/%+/&."4&9:;&-,<=&!#>&:;&-,?@A

#*)1*/7"2&&& 12:+"#"*"$%# "%*/)%1*"$%16& ./3"216 21%13"1%& ./3"216 21%13"1%&& )/2)/1*"$%16&&&

<@@B

:;&-,<=

?CB <CB <<B D<B

:;&-,?@

21%13"1%& ./3"216 ! 7EFEGHIEJ&KLEG&MCN@..& OF&7GKPP&)ELEFQE&KF&H& **.&RHPOP< ! 6EHJOFS&THGUEI&PVHGE&OF& 2HFHJOHF&)EWGEHIOKFHX& THGUEI& ! 3OLEGPOYOEJ&GELEFQE&TOZ& JGOLEF&R[&KGSHFOW&SGK\IV& HFJ&PIGHIESOW&HW]QOPOIOKFP

BI WV%HXBC%*,%WU%HXTYJ

VISION & OPPORTUNITY

DRIVE CONVERSION FROM ILLICIT TO REGULATED MARKET

D

2KTROFEJ&/PIOTHIEJ&.HGUEI&#O^E_&M5

BI 9Z[9G%%\-,),6#-%Z)$#5"*$G%!"(%]#)*('%,/%^:'%S#$-,)*()*G%_+)%TYB`G%#)%;<SG%@(-'(+*#,)+3%+)1%a(1#-+3%-,68#)(1J TI a+'#L:+)+%[:$#)($$%H+-*8,,4%b*"%\1#*#,)%c%9+))+8#$%S+*+G%TYBd%#)%;<SG%@(-'(+*#,)+3%+)1%a(1#-+3%-,68#)(1J UI =',"#8#*#,)%=+'*)('$G%\:',&(+)%9+))+8#$%@(&,'*G%<(-,)1%\1#*#,)G%TYBb%e%H#/*"%\1#*#,)G%TYTYG%#)%;<SJ

C <>N CN>; N>? NN>D @>;

B T U

"66"2"* )/7+61*/3

VISION & OPPORTUNITY

CANNABIS GLOBAL MARKET OPPORTUNITY

`

Countries With / Exploring Legal Cannabis Framework

40+

/PIOTHIEJ& M?D@5`&*1.<

8OIVOF&<D&[EHGP& "FWXQJOFSa +>#>&)EW&HFJ&.EJOWHX& b<@@5 2HFHJH&)EW&HFJ&.EJOWHX b<<5

?CD <=D NN ;;D? <@<; c@C

@ D@ <@@ <D@ ?@@ ?D@ ;@@ ;D@ C@@ 1XWKVKX *KRHWWK 2HFFHROP

/PIOTHIEJ&2HFFHROP& #HXEP&LP>&$IVEG&2(7& 2HIESKGOEP&OF&2HFHJH&'& +>#>&9OF&213&M5A

BI 9,)$*(33+*#,)%($*#6+*($G%9+),&F%($*#6+*($G%a+'#L:+)+%[:$#)($$%S+#3F%H+-*8,,4%TYBCG%#)%;<SJ TI <*+*#$*+G%A:5:$*%TYBCJ UI 9,0()G%\N:#*F%@($(+'-"G%!,8+--,%!Aa%;&1+*(O%\2-#5$%?($$%S#$':&*#>(G%9"+)5(%#)%;J<J%9#5+'(**(%!Aa%Ef%#)%8)IG%_+):+'F%TYTYJ VI TYBd%a+'#L:+)+%[:$#)($$%H+-*8,,4%b*"%\1#*#,)%c%9+))+8#$%S+*+G%TYBdJ DI a+'-"%TYTYG <*+*$%9+)+1+G%S(*+#3(1%",:$(",31%/#)+3%-,)$:6&*#,)%(K&()1#*:'(G%9+)+1+G%N:+'*('3FJ `I 9Z[9G%%\-,),6#-%Z)$#5"*$G%!"(%]#)*('%,/%^:'%S#$-,)*()*G%_+)%TYB`J bI !AaG%#)-3:1#)5%8,*"%Z33#-#*%+)1%@(5:3+*(1%6+'4(*$J

M;Dd M<<d McNc

+>#> 21%131

VISION & OPPORTUNITY

RECRUIT NEW ADULT CONSUMERS TO THE CANNABIS MARKET

b

\SZ[?\G%gA=\G =@\2@^??%AhS%^!Q\@ H^@a%HA9!^@<%9^a[Zh\SG ;J<J%<A?\<%aZi%j@\] H@^a ;DB&"%&?@<DG !^%D=B&"%&?@<d

VISION & OPPORTUNITY

ADD NEW CONSUMPTION OCCASIONS THROUGH NEW FORM FACTORS

d

.KGE&*VHF& <eOFeC&(EKfXE& "FIEFJ& *K&+PE& 2HFFHROP& 5ELEGHSEP<

BI 9,0()P$%9+)+1#+)%9+))+8#$%<:'>(F%Ea+F%TYBCG%)klBbYYI

!"#"$%&'&$(($)*+%"*,

• )$.&"%!/#*./%*&(01#/&*$&1&-$2+#/3&/4/2+*"$%&(01#/

5+"63"%7&5)1%3#&1%3&()$3+2*#&$-&*$31,&1%3&*$.$))$8 2$.."**/3&*$&3/6"!/)"%7&#01)/0$63/)&!16+/

KEY THEMES

C

PIVOTING FROM INVESTMENT PHASE TO A FOCUSED EXECUTION PHASE

NEW LEADERSHIP TEAM’S KEY PRIORITIES

BY

!"#$%"#&'()*'+,#*)#-".)/"0 ! !"!"#$%&'()!'#*(+! #$%&'()&*(#' ! !"+#$,","!%$'-./#-.-+$!+01+#'-.-#+.&'/ ! !"0(",+*/21' -#+.&'/"*0&*"-&'"%,',$&*,"0"$+*+3'.!/$4.,1"5 ! !"*(%$*'- &'1"!('-+21' .&$*',$"*#"&22"3*&4,0#21,$3

BB

PIVOTING FROM INVESTMENT PHASE TO A FOCUSED EXECUTION PHASE

FOCUS ON WINNING IN CANADIAN RECREATIONAL MARKET

g<&()"%2/& /381)3&"#61%3

;DB

g< %$!1&#2$*"1

?<B

g< $%*1)"$

?;B

g< 165/)*1

;=B

g< %1*"$%16 ??B

<,:'-(G%+%-,68#)+*#,)%,/%<*+*$%9+)+1+G%Z)/,'6+*#,)%$:86#**(1%8F%&',>#)-($G%+)1%9j9%#)*(')+3%#)/,'6+*#,)J% a+'4(*%<"+'(%#$%8+$(1%,)%@(*+#3%<"+'(%,/%S,33+'$J

BI [,/A%<(-:'#*#($G%H(8':+'F%TdG%TYTYO%9+)+1+%-+))+8#$%$*,'(%*'+-4('O%mUd%$*,'($%#)%3+$*%T%0((4$%,/%H(8':+'FJ TI BBYY%$*,'($%8+$(1%,)%+&&3F#)5%(N:#>+3()*%$*,'(%&('%-+&#*+%/,'%9+)+1+%(K2^h%+)1%W9%EB%&('%TBGYYYI%+$%,/% H(8':+'F%TYTYJ%TUYY%<*,'($%8+$(1%,)%+&&3F#)5%(N:#>+3()*%$*,'(%&('%-+&#*+%/,'%9,3,'+1,G%;<%EB%&('%BYGYYYIJ

PIVOTING FROM INVESTMENT PHASE TO A FOCUSED EXECUTION PHASE

A SIZABLE OPPORTUNITY IN CANADA TO CAPTURE INCREASED NUMBER OF RETAIL STORES

=@=

%1*"$%16<

2+))/%*a $%&'&:2&N@B&KY&(Kf>_ h&<@B&KY&#IKGEP&9cDA .1)i/*&3/.1%3a $%&'&:2&PVKQXJ VHLE&REI\EEF <<@@&HFJ&?;@@? PIKGEP

BT

:2 $%

PIVOTING FROM INVESTMENT PHASE TO A FOCUSED EXECUTION PHASE

REMAIN A TRUSTED PARTNER IN CANADA MEDICAL MARKET

BU

5d`GUYYm%"(+3*"-+'(%&',/($$#,)+3%

>#$#*$B

5?(+')#)5%6,1:3($%+--'(1#*(1%8F%

9+)+1#+)%="+'6+-F%A$$,-#+*#,)

5=#3,*%&',5'+6%0n%^)*+'#,%?,)5%

!('6%9+'(%A$$,-#+*#,)

5\23(+')#)5%6,1:3($%0n%!'((%,/%

• ),03(15(J%%?+:)-"(1%#)%bV%

]+36+'*%$*,'($%+-',$$%9+)+1+

BI 9:6:3+*#>(%$#)-(%#)-(&*#,)G%>#$#*$%+)1%-,)/('()-(%&'($()*+*#,)$J%%_+):+'F%TYTY

PIVOTING FROM INVESTMENT PHASE TO A FOCUSED EXECUTION PHASE

BUILD A LEADERSHIP POSITION IN THE U.S.

BV

+>#>&253&.HGUEI&HXGEHJ[&HI&MC5j&YKGEWHPI&IK&GEHWV&M?@5&R[&?@?D<

! BVp%,/%A6('#-+)$%:$#)5%9[S%&',1:-*$G%&('%

_:3F%TYBC%j+33:&%=,33

! ^>('2#)1(K($%#)%Bd2UV%F(+'%,31%$(56()* ! <*+*(28F2$*+*(%'(5:3+*#,)%5,>(')$%

&('6#$$#8#3#*F%8F%/,'6%/+-*,'$

! A0+#*#)5%-3+'#/#-+*#,)%/',6%*"(%HSA%,)%+%

'(5:3+*,'F%/'+6(0,'4%#)%#)5($*#83($

*OFWIQGEP_&C<B *KfOWHXP_& ;<B 2HfPQXEP_& ?DB 5ELEGHSEP_&<=B $IVEGP_& ?@B

;J<J%9[S%;<Aj\%[X%H^@a%HA9!^@

BI <,:'-(O%9,0()%e%9,6&+)FG%['#5"*/#(31%j',:&G%!"(%j+33:&G%#)%;<SJ

PIVOTING FROM INVESTMENT PHASE TO A FOCUSED EXECUTION PHASE

BUILD A LEADERSHIP POSITION IN THE U.S.

Planned Acquisition of MSO Acreage Holdings on Cannabis Federal Permissibility1

BI A''+)5(6()*%+&&',>(1%8F%9+),&F%j',0*"%+)1%A-'(+5(%$"+'(",31('$G%#6&3(6()*(1%,)%_:)(%TbG% TYBCG%+-N:#$#*#,)%*'#55('(1%,)%;J<J%/(1('+3%&('6#$$#8#3#*F%,/%-+))+8#$J TI 9+),&F%*,%3#-()$($%Z)*(33(-*:+3%=',&('*F%+)1%8'+)1$%*,%A-'(+5(%,)%+%),2/((%8+$#$J

1WGEHSE&6ELEGHSOFS&2HFKf[&"(?

5

*\EEJeRGHFJEJ&YXK\EG&XHQFWVEJ&OF&"6_&./_&.1_&HFJ& $)_&OFWGEHPOFS&FQTREG&KY&*\EEJ&PIGHOFP&HLHOXHRXE&OF& ?@?@

5

(XHFP&IK&EZfHFJ&*\EEJeRGHFJEJ&fGKJQWI&KYYEGOFSP_& OFWXQJOFS&fGEeGKXXP&HFJ&LHfE&WHGIGOJSEP_&OFIK&TKGE& PIHIEP&OF&?0&2,?@?@_&IK&RQOXJ&RGHFJ&WKHPIeIKeWKHPI

BD

!"#"$%&'&$(($)*+%"*,

• )$.&"%!/#*./%*&(01#/&*$&1&-$2+#/3&/4/2+*"$%&(01#/

5+"63"%7&5)1%3#&1%3&()$3+2*#&$-&*$31,&1%3&*$.$))$8

2$.."**/3&*$&3/6"!/)"%7&#01)/0$63/)&!16+/

KEY THEMES

B`

Bb

Bd

BUILDING BRANDS AND PRODUCTS OF TODAY AND TOMORROW

FLOWER & PRE-ROLL JOINTS - MARKET SEGMENTATION

$QG&XHGSEPI&RGHFJ&OF&5?5& GEWGEHIOKFHXj&VOSVX[&WQGHIEJj& RGKHJ&HffEHX< $QG&LHXQE&RGHFJj&SGE\&IK& FEHGX[&?@B&KY&KQG&PHXEP&TOZ& HP&KY&;:&-,?@< 1&fGETOQT&YXK\EGkfGEeGKXX& lKOFI&RGHFJj&65#&#QFPEI&Qf& KLEG&D@B&OF&;:&-,?@<

BI p%,/%9+),&FP$%'(&,'*(1%9+)+1#+)%'(-'(+*#,)+3%[T[%$+3($J

BC

2HFFHROPeOFYQPEJ&WGHYI&WVKWKXHIE& fGKJQWEJ&OF&WKXXHRKGHIOKF&\OIV& H\HGJe\OFFOFS&WVKWKXHIE&THUEG_& 0QTTOFSROGJ&2VKWKXHIE ;&JOPIOFWI&m5EHFeIKeRHGn&fGKJQWIP& QFJEG&IVE&*\EEJ_&*KU[K&#TKUE&HFJ& 5EHF&'&5QJ&RGHFJP 2KFIHOF&Qf&IK&H&XOTOI&KY&<@&TOXXOSGHTP& KY&*02&fEG&fHWUHSE&KY&WVKWKXHIE BUILDING BRANDS AND PRODUCTS OF TODAY AND TOMORROW

EDIBLES

TY

BUILDING BRANDS AND PRODUCTS OF TODAY AND TOMORROW

VAPES

• +o+&o$"%*#p&#OFSXEeQPE_&GEHJ[eIKe

SK_&GEW[WXHRXE_&5XQEIKKIVeEFHRXEJ_& +6&=<;d&WEGIOYOEJ> (HOG&\OIV& 1FJGKOJ&PTHGIfVKFE&LOH&o+o+& *EWVp&Hff>

• +o+&(K\EGp&D<@&)EWVHGSEHRXE&

5HIIEG[&!HfE&(EF&\k&RQIIKFXEPP& HWIOLHIOKF_&+6&=<;d& WEGIOYOEJ 2HGIGOJSEP&OF&*\J>_&*\EEJ_& HFJ&!HF&3EG&(Kf&RGHFJP&OF&YHTOXOHG& D<@&IVGEHJEJ&YKGTHI>

1XX&3ELOWEP&\OXX&KRIHOF&+6&=<;d&PHYEI[&WEGIOYOWHIOKF

*KU[K&#TKUE&6QTH&e +6&=<;d&WEGIOYOEJ& LHfE&P[PIET&\OIV&GEWVHGSEHRXE& RHIIEGOEP&YEHIQGE&fGEWOPE&WEGHTOW& VEHIOFS&IEWVFKXKS[&HFJ&YEHIQGE&"FIEFIe WKXKGEJ&TKQIVfOEWEP>

VAPES

1XX&3ELOWEP&\OXX&KRIHOF&+6&=<;d&PHYEI[&WEGIOYOWHIOKF

*KU[K&#TKUE&6QTH& +6&=<;d&WEGIOYOEJ& LHfE&P[PIET&\OIV&GEWVHGSEHRXE&

TB

BUILDING BRANDS AND PRODUCTS OF TODAY AND TOMORROW

BEVERAGES

5 #KfVOPIOWHIEJ&IHPIE&\OIV&H&GHFSE&KY&YXHLKG&fGKYOXEP&IK& PHIOPY[&H&\OJE&LHGOEI[&KY&WKFPQTEG&IHPIEP> 5 6K\&WHXKGOEP_&FK&mVHFSKLEG>n 5 #EGLOFS&KY&?&TS&KY&*02&OP&OJEHX&YKG&WKFPQTEGP_&HP&OI& HXXK\P&YKG&TKGE&WKFIGKX>&*VOP&OP&QFXOUE&\VHI&\E&PEE& OF&+>#>&THGUEIP_&\VEGE&VOSVEG&PEGLOFSP&KY&<@@&TS&HGE& WKTTKF> 5 <@&)*3P_&(GEeTOZEJ&\OIV&3OPIOXXEJ&2HFFHROP*.> 5 ;&3OPIOXXEJ&2HFFHROP*. RELEGHSE&TOZEGP&IVHI&WHF&RE& WKTROFEJ&\OIV&FKFeHXWKVKXOW&RELEGHSEP> 6K\&WHXKGOEP_&FK&mVHFSKLEG>n #EGLOFS&KY&?&TS&KY&*02&OP&OJEHX&YKG&WKFPQTEGP_&HP&OI& HXXK\P&YKG&TKGE&WKFIGKX>&*VOP&OP&QFXOUE&\VHI&\E&PEE& OF&+>#>&THGUEIP_&\VEGE&VOSVEG&PEGLOFSP&KY&<@@&TS&HGE& WKTTKF> <@&)*3P_&(GE ;&3OPIOXXEJ&2HFFHROP

TT

BUILDING BRANDS AND PRODUCTS OF TODAY AND TOMORROW

CBD

j3,8+3%3(+1('%#)%)+*:'+3 $4#)-+'(%+)1%$3((&%$,3:*#,)$ S(>(3,&#)5%)(0%3#)(%,/%$4#)-+'(%+)1%$3((&% $,3:*#,)%&',1:-*$%#)/:$(1%0#*"%9[SG% (K&(-*(1%#)%6+'4(*%8(5#))#)5%TQ%9XTY <*',)5%&3+*/,'6%*,%()*('%*"(%$&,'*$% ):*'#*#,)%6+'4(* =+'*)('$"#&$%0n%;<A%Q,-4(FG%9+)+1+% [+$4(*8+33G%A*"3(*#-$%9+)+1+%+)1%*"(% =',/($$#,)+3%Q,-4(F%=3+F('$%A$$,-#+*#,)G% +)1%6+'4(*#)5%0n[',,43F)%h(*$ ;J<J%?+:)-"%2 BB%<o;P$% ,)%$"(3/%#)%!"(%g#*+6#)%<",&&( Q(6&21('#>(1%9[S%&',1:-*%3#)(%,//('(1%#)% +%>+'#(*F%,/%/,'6+*$G%#)-3:1#)5%$,/*5(3$%G,#3% 1',&$%+)1%-'(+6$ ?+:)-"(1%D%<o;P$%,)3#)(%#)%;J<J =3+)$%*,%(K&+)1%&',1:-*%,//('#)5%+)1% 1#$*'#8:*#,)%,>('%*"(%-,:'$(%,/%HXTB

TU

BUILDING BRANDS AND PRODUCTS OF TODAY AND TOMORROW

DIVERSIFYING OUR CANNABIS BUSINESS

/QGKfEqP&XHGSEPI&WHFFHROFKOJeRHPEJ& fVHGTHWEQIOWHXP&THFQYHWIQGEG& ?(+1#)5%6+):/+-*:'('%+)1%1#$*'#8:*,'%,/% 1',)+8#),3G%+%'(5#$*('(1%&"+'6+-(:*#-+3%1':5%#)% j('6+)FG%A:$*'#+G%<0#*M('3+)1G%+)1%S()6+'4 9U $:&&3#(1%+&&',K#6+*(3F%BCGDYY%&+*#()*$%#)% j('6+)F%0#*"%1',)+8#),3%#)%TYBd D%+&&',>(1%*"('+&#($%,)%6+'4(* <&(-*':6%!"('+&(:*#-$%*,%&'($()*%(K&+)1(1G% 6(1#-+33F%>+3#1+*(1%$:#*(%,/%-+))+8#),#1%*"('+&#($ \K&,'*$%6(1#-+33F%+&&',>(1%>+&,'#M('$%*,% DY%6+'4(*$%53,8+33FG%0n%"(+*2),*28:')% *(-"),3,5F [:#31#)52,:*%*"(%-+&+-#*F%,/%<e[% 6+):/+-*:'#)5%/+-#3#*#($ j'(()3+)(%"+$%(K-3:$#>(% 1#$*'#8:*#,)%'#5"*$%*"',:5",:* *"(% ;J<JG%0"#-"%#)-3:1($%,>('%BBo% '(*+#3%3,-+*#,)$

<;@`&(1*/%*#_&;D@`&(1*/%*& 1((6"21*"$%#&-"6/3&*$&31*/_& .1%,&.$)/&+%3/)&3/!/6$(./%*

BUILDING BRANDS AND PRODUCTS OF TODAY AND TOMORROW

SUPPORTED BY R&D & IP PROTECTION PROGRAMS

HUMAN HEALTH CLINICAL TRIALS INCLUDING PHASE IIB SLEEP, PAIN, ANXIETY AND PHASE III SPASTICITY/MULTIPLE SCLEROSIS1

60

ANIMAL HEALTH CLINICAL TRIALS INCLUDING COMPANION ANIMAL ANXIETY1

4

PHARMACOKINETICS, DOSAGE & SAFETY TRIALS1 AFFILLIATE AND PARTNER RESEARCH PROGRAMS (OPIOD-SPARING, SMOKING CESSATION, CONCUSSION TREATMENT)

3

<A 2KTfXEIEJ_&KFSKOFS&KG&OF&fXHFFOFS>

CANNABIS-BASED MEDICAL THERAPY R&D BUILDING OUR ECONOMIC MOAT

! 9+))+8#$28+$(1%8(>('+5(%&',1:-*#,) ! 9+))+8#$28+$(1%*"('+&(:*#-$ ! S(>#-(%e%1(3#>('F%*(-"),3,5#($ ! ?+'5(2$-+3(%-+))+8#$%&',-($$#)5 ! 9+))+8#$%&3+)*%5()(*#-$ ! [',+1%5(,5'+&"#-%-,>('+5(

?C

!"#"$%&'&$(($)*+%"*,

• )$.&"%!/#*./%*&(01#/&*$&1&-$2+#/3&/4/2+*"$%&(01#/

5+"63"%7&5)1%3#&1%3&()$3+2*#&$-&*$31,&1%3&*$.$))$8

2$.."**/3&*$&3/6"!/)"%7&#01)/0$63/)&!16+/ KEY THEMES

TD

T`

COMMITTED TO DELIVERING SHAREHOLDER VALUE

OUR MEDIUM TERM TARGETS

! 6#3(*(7,"89&$*,$2/"!1:93*,1";<=>?!@ ('"

A&'&1&"B/"C8"DEF@

! 6#3(*(7,"89&$*,$2/"!1:93*,1";<=>?!@ G#$"

*0,"*#*&2"-#+.&'/"B/"C8"DEFF

! 6#3(*(7,"H,*"='-#+,"I(*0('"DEFJKDEFL"

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a+'-"%UBG%TYTBJ UI 9,)$,3#1+*(1%-,'&,'+*(%,&('+*#,)$%*,%1(3#>('%=,$#*#>(%A1L:$*(1%\[Z!SA%,)%+%N:+'*('3F%8+$#$%8F%*"(%N:+'*('%()1(1%a+'-"%UBG%TYTTJ%

LEADERSHIP

Rade Kovacevic President Mike Lee EVP & CFO David Klein CEO

Tb

Td

THANK YOU